Neha Lodha

Dr. Neha Lodha is an engineer-turned-neuroscientist. She is a tenured associate professor in the Department of Health and Exercise Science and the School of Biomedical Engineering at Colorado State University (CSU). She earned her PhD in kinesiology from the University of Florida, following a BTech in information and communication technology from DA-IICT, Gandhinagar, India.

Dr. Lodha directs the Laboratory of Movement Neuroscience and Rehabilitation at CSU. Her research applies approaches in cognitive aging, movement neuroscience, and neurorehabilitation with the goal of improving functional independence, mobility, and overall well-being of individuals facing age-related or neurological challenges. Her interdisciplinary approach bridges biomechanics, neuroscience, and digital health to better understand and support cognitive and physical functioning in everyday life. Her current work in her lab focuses on identifying early indicators of reduced mobility and cognitive performance. This includes examining how people move in their daily environments, how their cognitive and motor systems interact, and how technology can assist in rehabilitation and health monitoring. Complementing her research, Dr. Lodha leads community outreach through her lab’s initiatives. These include mobility assessments and fall-prevention screenings for older adults, as well as educational programs for students interested in science and engineering.

Dr. Lodha has authored over 50 scholarly publications, including 40 peer-reviewed journal articles, and her work has been cited more than 3,400 times. She has a strong track record in securing external research funding as a principal investigator, having obtained competitive awards from agencies like the National Institute on Aging, the American Heart Association, and the Alzheimer’s Association.

The global rise of dementia significantly affects populations in low- and middle-income countries. In communities with limited access to formal education and healthcare, cognitive impairments often go undiagnosed. Most current assessments cater to English-speaking and literate individuals and are not effective for people in other contexts. Dr. Lodha’s Fulbright-Nehru project is developing a performance-based tool designed to work across language and education levels within the Indian population. The project’s primary aim is to improve early detection of cognitive decline.

Clara Navarro

Originally from Austin, Texas, Clara Navarro is a graduate of the United States Naval Academy. At the academy, Clara majored in Chinese and researched in the anthropology department where she published on the subject of gender relations in the military.

Upon graduation, Clara served in the United States Navy aboard the USS Abraham Lincoln where she was the deputy public affairs officer and principal assistant of the Media Department. Along with the crew, she completed a record-breaking around-the-world deployment from Norfolk, Virginia, to San Diego, California. Returning to land, she worked for two years as the media officer for the Europe, Africa, Central Navy Region headquarters in Naples, Italy. In this role, she coordinated communication between eight naval bases and seven host-nation embassies.

Honorably discharged from the Navy in 2022, Clara then earned a post-baccalaureate, pre-medical certificate at George Washington University in Washington, D.C., fulfilling the course requirements to apply to medical school. She is currently applying to medical schools across America.

Working with India’s National Institute of Mental Health and Neurosciences, Clara’s Fulbright-Nehru project is researching integrative mental healthcare services in the South Indian state of Karnataka. In a three-phase approach, her project is being executed first through archival research and clinical observation, then via interviews with practitioners and patients, and lastly, by reflection and synthesis. She is also assessing the hybrid practice of Ayurveda and allopathic mental healthcare that is growing in prevalence in India by focusing on both its successes and limitations, as well as on its impact on the community.

Sahita Manda

Sahita Manda is a recent graduate of the University of Michigan’s School of Public Health with a BS in public health sciences and a minor in biochemistry. She has had a longtime interest in working with people with disabilities, both through her research exploring stigma and neurodiversity as well as through her volunteer work. Sahita is also greatly interested in health policy and has interned at the Bipartisan Policy Center, a Washington, D.C.-based think tank. She hopes to pursue a career as a physician by integrating the principles of medicine and public health.

For her Fulbright-Nehru fellowship, Sahita is conducting nine months of research at the National Institute of Mental Health and Neurosciences in Bengaluru, India. She is exploring parental perspectives and experiences related to seeking clinical and non-clinical services for adolescents with autism spectrum disorder (ASD); she is also examining the navigation of the physical, sexual, cognitive, social, and emotional changes that come with adolescence. Sahita is also studying the lived experiences of adolescents with ASD. Using aggregated data from semi-structured interviews, she is identifying the current gaps in services and opportunities for this population, with the eventual goal of informing the development of culturally appropriate, holistic care.

Sanjeev Chawla

Dr. Sanjeev Chawla is a research assistant professor in the Department of Radiology, Perelman School of Medicine, University of Pennsylvania. He is also a medical physicist certified by the American Board of Medical Physics. The focus of Dr. Chawla’s research has been directed toward the development of metabolic and physiological MR imaging-derived biomarkers in making correct diagnosis and assessing treatment responses to established, novel, and emerging therapies in patients with brain tumor, head and neck cancer, and neurodegenerative diseases.

He has a master’s degree in chemistry from the Indian Institute of Technology Delhi and a PhD in radiology from Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow. He has authored 103 peer-reviewed original research/review articles and eight book chapters. He has been awarded research grants by agencies like the National Institute of Health/National Cancer Institute, the International Society for Magnetic Resonance in Medicine, and the Penn Center for Precision Medicine. Currently, he is leading two clinical trials related to electric field therapy in glioblastomas (NCT05086497) and evaluation of treatment response in the case of salivary gland tumors (NCT04452162).

Dr. Chawla is also an associate editor with the Journal of Translational Medicine and a reviewer for several leading scientific journals. Earlier, he was a guest editor with Frontiers in Neurology. He has also won the Outstanding Researcher Award in Neuroradiology from the Venus International Foundation and the Leadership and Mentorship Scholarship Award from the National Cancer Institute Awardee Skill Development Consortia.

Dr. Chawla’s Fulbright-Nehru project is building a robust, reproducible, and objective clinical decision support (CDS) tool by incorporating physiologic and metabolic MR imaging-derived parameters and molecular signatures combined with machine learning algorithms for assessing treatment response in glioblastoma patients receiving standard treatment as well as novel therapies. This tool will not only facilitate accurate and timely differentiation of true progression and pseudo progression in glioblastomas (precision diagnostics) but also allow clinicians to make “go/stop” decisions on therapeutic interventions (precision therapeutics). Additionally, it will help to relieve “scanxiety” among patients and their loved ones.